Nage Stock Analysis Niagen Bioscience Inc. Falls 3.10 To 4.38 Amid Biotech Market Shifts 20260403 EEOC Considers Ending Employer Demographic Data Reporting Requirements LIVE Q1 2026 Earnings EPS of 023 Reported Amid Sparse Disclosure Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues Bill Ackman Builds Microsoft Stake in First Quarter Betting on AI and Cloud Momentum WTBA Q1 2026 Earnings Earnings Beat Estimates on Solid Performance DOLE Q1 2026 Earnings EPS Misses Estimates Despite Strong Operational Execution